Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Drug-Coated Balloons Market Expected to Grow Between 2025 And 2029?

In recent times, the size of the market for drug-coated balloons has seen significant growth. It is forecasted to expand from $1.08 billion in 2024 to $1.24 billion in 2025 with a compound annual growth rate (CAGR) of 14.6%. This growth over the historical period has been driven by a rise in cardiovascular disease cases, increased demand for less invasive procedures, a higher prevalence of peripheral artery disease (PAD), lower rates of restenosis, and advancements in the field of interventional cardiology.

The market size of drug-coated balloons is projected to witness a swift expansion in the coming years. An expected rise to $2.2 billion by 2029 is predicted, with a compound annual growth rate (CAGR) of 15.5%. This growth over the forecast period can be credited to factors such as a growing aging populace, broadening of indications and applications, a shift towards outpatient and ambulatory care, merging with advancements in drug delivery, and worldwide health initiatives. The forecast period will also see significant trends such as approval of new formulations from regulators, emphasis on reducing side effects, development of bioresorbable coatings, market growth in developing economies, and patient-centered strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

What Are the Core Growth Drivers Propelling the Drug-Coated Balloons Market Forward?

The anticipated escalation in occurrences of coronary artery disease is presumed to drive the growth of the drug-coated balloons market. Coronary artery disease (CAD) is a medical term for the restriction or blockage of the coronary arteries that supply blood to the heart muscle, resulting in heart attacks. Drug-coated balloons are medical devices utilized in the treatment of this disease. The drug is administered into the artery during the procedure to minimize the chances of restenosis, a condition where the artery re-narrows after angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 suggested that all four cardiovascular risk factors, namely diabetes, dyslipidemia, hypertension, and obesity, are projected to rise in the U.S. between 2025 and 2060. The study showed that diabetes will surge by 39.3% followed by dyslipidemia at 27.6%, hypertension’s rise at 25.1%, and obesity’s increase at 18.3%. The research also found that heart failure and ischemic heart disease will potentially experience the greatest surges at 33.4% and 30.7% respectively. Heart attacks and stroke also have anticipated increases of 16.9% and 33.8% respectively. Therefore, this increase in instances of coronary artery disease is foreseen to catalyze the expansion of the drug-coated balloon market.

What Segment Types Define the Drug-Coated Balloons Market Structure?

The drug-coated balloonsmarket covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons

3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theDrug-Coated Balloons Industry Evolution?

The rise in product innovations is a crucial trend observed in the drug-coated balloon market. Businesses in this market are concentrating on the creation of new technologies and inventive solutions as a means to consolidate their market presence. For instance, Becton, Dickinson, and Company (BD), a medical technology company based in the US, initiated the first human trial of the PREVISION peripheral sirolimus drug-coated balloon (DCB) in August 2022. This trial is being conducted to evaluate the safety and performance of the sirolimus DCB in managing patients with peripheral artery disease, a malady that drastically affects mobility and quality of living.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

What Is the Definition of the Drug-Coated Balloons Market?

A drug-coated balloon (DCB) is a medical device used in the treatment of narrowed or blocked blood vessels, primarily in the field of interventional cardiology and interventional radiology. It is designed to deliver medication directly to the site of vascular disease while simultaneously performing angioplasty.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model